Home Home Home Inbox Home Search

Event

FASENRAâ„¢ (benralizumab) Subcutaneous Injection 30 mg: A Targeted Approach

Location: THEATER 1
Session Type: Industry Theaters
Sunday
May
20
11:30 AM
12:15 PM

Description

You are cordially invited to attend a program to learn more about emerging mechanisms of disease and a treatment option for appropriate patients. By focusing on the underlying mechanism of disease, treatment can be tailored to the needs of individual patients. Join a national expert to explore the role of a targeted treatment option, its clinical efficacy and safety data, mechanism of action and tips for appropriate patient identification.
Home Home Home Inbox Home Search